Aims/Methods: Four assays for measuring HBV-DNA quantitatively have be
en compared with regard to sensitivity, precision and linearity. The m
ethods were I-125-labelled solution hybridisation assay (liquid hybrid
isation, Abbott), an ELISA-based chemiIuminescent RNA-DNA hybrid assay
(RNA-DNA, Digene), a chemilumimescent branching oligonucleotide assay
(bDNA, Chiron) and a membrane hybridisation assay using slot-blot equ
ipment (slot blot). Results: The bDNA assay was linear over three orde
rs of magnitude and was the most sensitive assay, being approximately
ten times more sensitive than the other assays, so that samples negati
ve on RNA-DNA, liquid hybridisation and slot blot gave quantifiable re
sults on bDNA, Furthermore, intra- and inter-assay variability showed
that the bDNA and liquid hybridisation assays had the greatest precisi
on, with coefficients of variation of 6.6% to 11.5% and 2.3% to 10.5%,
respectively. However, the nominated amounts of HBV DNA in the standa
rds (from all assays) were plot reproducible in the other assays, such
that amounts measured with bDNA would give values approximately twice
that of RNA-DNA and 60 times that of liquid hybridisation. Conclusion
s: The recently developed bDNA assay has advantages compared with the
other assays in quantitating samples with low levels of virus present,
In addition, since the assays vary considerably by a number of criter
ia, the method of measurement should always be reported.